Navigation Links
CIC Closes Financing Round
Date:1/3/2011

Phoenix is a private equity fund that specializes in making concentrated investments in publicly traded companies in North America. Phoenix is co-managed by Philip Sassower, CEO, and Andrea Goren, Managing Director. Mr. Sassower is currently CIC's Chairman and CEO, while Mr. Goren is the Company's Acting CFO.

Forward Looking StatementsCertain statements contained in this press release, including without limitation, statements containing the words "believes", "anticipates", "hopes", "intends", "expects", and other words of similar import, constitute "forward looking" statements within the meaning of the Private Litigation Reform Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors, which may cause actual events to differ materially from expectations.  Such factors include the following (1) technological, engineering, quality control or other circumstances which could delay the sale or shipment of products containing the Company's technology; (2) economic, business, market and competitive conditions in the software industry and technological innovations which could affect the Company's business; (3) the Company's inability to protect its trade secrets or other proprietary rights, operate without infringing upon the proprietary rights of others or prevent others from infringing on the proprietary rights of the Company; and (4) general economic and business conditions and the availability of sufficient financing.Contact Information:CICInvestor Relations & Media Inquiries:Andrea Goren+1.650.802.7723agoren@cic.com
'/>"/>

SOURCE Communication Intelligence Corporation (CIC)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology news :

1. Mans closest relationship under strain? New research reveals why chimpanzees attack humans
2. Molecular Biometrics Closes $12.5 Million Series B Equity Funding
3. In the war between the sexes, the one with the closest fungal relationship wins
4. CIC to Raise $2.2 Million in Financing and Announces Changes in Management
5. KINAXO Completes Financing Round to Enhance Biomarker Development
6. EmSense Raises $9 Million Series C Round of Financing
7. PDC Biotech GmbH Announces Close of Series A Financing
8. Pacific Biometrics Completes $4 Million Debt Financing
9. Satellite data provide a new way to monitor groundwater in agricultural regions
10. GEN co-sponsors roundtable discussion on novel bioremediation techniques
11. Can cacti escape underground in high temperatures?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... G. Fujimoto, Ph.D ., the Elihu Thomson Professor of Electrical Engineering and Computer ... Research Award winner. Presented annually, the award recognizes an individual who has ...
(Date:7/20/2017)... ... , ... VIC Technology Venture Development™ (VIC™), is pleased to announce ... addition continues to strengthen and diversify VIC’s board. , "We are excited to have ... highly accomplished business executive with a broad range of experience directly relevant to VIC ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... solution to make clinical trial sites and study participants truly unified. TrialKit, a ... compliant (FDA 21 CFR Part 11) research studies entirely on mobile devices. With ...
(Date:7/18/2017)... , ... July 18, 2017 , ... ... the United States Patent and Trademark Office for its Patent Applications 14/858,857 and ... Office’s allowances of these patent applications further expand the protection of G-CON’s R&D ...
Breaking Biology Technology: